Published in J Biol Chem on November 05, 1999
Negligible genetic diversity of mycobacterium tuberculosis host immune system protein targets: evidence of limited selective pressure. Genetics (2000) 2.63
Chapter 2: Biogenesis of the cell wall and other glycoconjugates of Mycobacterium tuberculosis. Adv Appl Microbiol (2009) 1.84
Diversity in Mycobacterium tuberculosis mannosylated cell wall determinants impacts adaptation to the host. Tuberculosis (Edinb) (2010) 1.50
Rhodococcus erythropolis as a host for expression, secretion and glycosylation of Mycobacterium tuberculosis proteins. Microb Cell Fact (2017) 1.38
A heterologous DNA priming-Mycobacterium bovis BCG boosting immunization strategy using mycobacterial Hsp70, Hsp65, and Apa antigens improves protection against tuberculosis in mice. Infect Immun (2004) 1.21
The cell envelope glycoconjugates of Mycobacterium tuberculosis. Crit Rev Biochem Mol Biol (2014) 1.06
Fibronectin attachment protein homologue mediates fibronectin binding by Mycobacterium avium subsp. paratuberculosis. Infect Immun (2001) 0.98
Expression, secretion, and glycosylation of the 45- and 47-kDa glycoprotein of Mycobacterium tuberculosis in Streptomyces lividans. Appl Environ Microbiol (2004) 0.94
Fibronectin attachment protein is necessary for efficient attachment and invasion of epithelial cells by Mycobacterium avium subsp. paratuberculosis. Infect Immun (2002) 0.93
Bacterial protein-O-mannosylating enzyme is crucial for virulence of Mycobacterium tuberculosis. Proc Natl Acad Sci U S A (2013) 0.93
The sweet tooth of bacteria: common themes in bacterial glycoconjugates. Microbiol Mol Biol Rev (2014) 0.91
O-mannosylation of the Mycobacterium tuberculosis adhesin Apa is crucial for T cell antigenicity during infection but is expendable for protection. PLoS Pathog (2013) 0.90
Cellular immune responses to nine Mycobacterium tuberculosis vaccine candidates following intranasal vaccination. PLoS One (2011) 0.88
The glycosylated Rv1860 protein of Mycobacterium tuberculosis inhibits dendritic cell mediated TH1 and TH17 polarization of T cells and abrogates protective immunity conferred by BCG. PLoS Pathog (2014) 0.88
Proteomic profile of culture filtrate from the Brazilian vaccine strain Mycobacterium bovis BCG Moreau compared to M. bovis BCG Pasteur. BMC Microbiol (2011) 0.88
O-linked glycosylation sites profiling in Mycobacterium tuberculosis culture filtrate proteins. J Proteomics (2013) 0.86
The O-mannosylation and production of recombinant APA (45/47 KDa) protein from Mycobacterium tuberculosis in Streptomyces lividans is affected by culture conditions in shake flasks. Microb Cell Fact (2011) 0.86
Toward Understanding the Essence of Post-Translational Modifications for the Mycobacterium tuberculosis Immunoproteome. Front Immunol (2014) 0.85
Enhanced patient serum immunoreactivity to recombinant Mycobacterium tuberculosis CFP32 produced in the yeast Pichia pastoris compared to Escherichia coli and its potential for serodiagnosis of tuberculosis. J Clin Microbiol (2006) 0.82
Recombinant BCG as a vaccine vehicle to protect against tuberculosis. Bioeng Bugs (2009) 0.79
Mycobacterial glycoproteins: a novel subset of vaccine candidates. Front Cell Infect Microbiol (2014) 0.77
A single dose of a DNA vaccine encoding apa coencapsulated with 6,6'-trehalose dimycolate in microspheres confers long-term protection against tuberculosis in Mycobacterium bovis BCG-primed mice. Clin Vaccine Immunol (2013) 0.76
Scrutiny of Mycobacterium tuberculosis 19 kDa antigen proteoforms provides new insights in the lipoglycoprotein biogenesis paradigm. Sci Rep (2017) 0.75
Boosting BCG-primed responses with a subunit Apa vaccine during the waning phase improves immunity and imparts protection against Mycobacterium tuberculosis. Sci Rep (2016) 0.75
Protein O-mannosylation deficiency increases LprG-associated lipoarabinomannan release by Mycobacterium tuberculosis and enhances the TLR2-associated inflammatory response. Sci Rep (2017) 0.75
Multimodality image registration by maximization of mutual information. IEEE Trans Med Imaging (1997) 16.80
Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands. Science (1994) 3.90
Complications of radiofrequency coagulation of liver tumours. Br J Surg (2002) 3.39
Persistence and protective efficacy of a Mycobacterium tuberculosis auxotroph vaccine. Infect Immun (1999) 2.70
Unipolar localization and ATPase activity of IcsA, a Shigella flexneri protein involved in intracellular movement. J Bacteriol (1993) 2.62
Spontaneous neurological recovery after stroke and the fate of the ischemic penumbra. Ann Neurol (1996) 2.54
Comparison between effective radiation dose of CBCT and MSCT scanners for dentomaxillofacial applications. Eur J Radiol (2008) 2.53
Nog2p, a putative GTPase associated with pre-60S subunits and required for late 60S maturation steps. EMBO J (2001) 2.44
Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: evidence for a negative signal delivered through the mannose receptor. J Immunol (2001) 2.20
Identification of the surface-exposed lipids on the cell envelopes of Mycobacterium tuberculosis and other mycobacterial species. J Bacteriol (1996) 2.19
Tuberculosis in HIV-infected patients: a comprehensive review. Clin Microbiol Infect (2004) 2.13
An iterative maximum-likelihood polychromatic algorithm for CT. IEEE Trans Med Imaging (2001) 2.09
Attenuation of virulence by disruption of the Mycobacterium tuberculosis erp gene. Science (1998) 2.00
Mast cell-dependent B and T lymphocyte activation is mediated by the secretion of immunologically active exosomes. J Immunol (2001) 1.91
Murine natural killer T(NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls. Proc Natl Acad Sci U S A (1999) 1.84
Isolation and flow cytometric analysis of the free lymphomyeloid cells present in murine liver. J Immunol Methods (1990) 1.76
Acylation state of the phosphatidylinositol mannosides from Mycobacterium bovis bacillus Calmette Guérin and ability to induce granuloma and recruit natural killer T cells. J Biol Chem (2001) 1.70
Titration and circulation of cells mediating delayed type hypersensitivity in normal and cyclophosphamide treated mice during response to sheep red blood cells. Immunology (1978) 1.64
Isolation and characterization of catalytic and calmodulin-binding domains of Bordetella pertussis adenylate cyclase. Eur J Biochem (1991) 1.63
Differential induction of apoptosis by virulent Mycobacterium tuberculosis in resistant and susceptible murine macrophages: role of nitric oxide and mycobacterial products. J Immunol (1997) 1.63
Identification of a Mycobacterium bovis BCG 45/47-kilodalton antigen complex, an immunodominant target for antibody response after immunization with living bacteria. Infect Immun (1993) 1.60
Cloning, sequencing, and expression of the apa gene coding for the Mycobacterium tuberculosis 45/47-kilodalton secreted antigen complex. Infect Immun (1995) 1.60
Lymph node metastases from head and neck squamous cell carcinoma: MR imaging with ultrasmall superparamagnetic iron oxide particles (Sinerem MR) -- results of a phase-III multicenter clinical trial. Eur Radiol (2001) 1.60
Methionine biosynthesis in Enterobacteriaceae: biochemical, regulatory, and evolutionary aspects. CRC Crit Rev Biochem (1988) 1.48
Cost of chickenpox in Canada: part I. Cost of uncomplicated cases. Pediatrics (1999) 1.47
Motion-responsive regions of the human brain. Exp Brain Res (1999) 1.47
Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis. Eur J Immunol (1987) 1.46
Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice. J Immunol (1986) 1.45
Structural features of lipoarabinomannan from Mycobacterium bovis BCG. Determination of molecular mass by laser desorption mass spectrometry. J Biol Chem (1993) 1.36
Clustered organization of homologous KRAB zinc-finger genes with enhanced expression in human T lymphoid cells. EMBO J (1993) 1.35
Characterization of the calmodulin-binding and of the catalytic domains of Bordetella pertussis adenylate cyclase. J Biol Chem (1989) 1.33
Deglycosylation of the 45/47-kilodalton antigen complex of Mycobacterium tuberculosis decreases its capacity to elicit in vivo or in vitro cellular immune responses. Infect Immun (1999) 1.32
Interactions of the Escherichia coli methionine repressor with the metF operator and with its corepressor, S-adenosylmethionine. J Biol Chem (1986) 1.32
Role of Mycobacterium tuberculosis copper-zinc superoxide dismutase. Infect Immun (2001) 1.32
A review of the general aspects of radiofrequency ablation. Abdom Imaging (2005) 1.31
Determination of phosphoenolpyruvate carboxykinase activity with deoxyguanosine 5'-diphosphate as nucleotide substrate. Anal Biochem (1979) 1.29
The mannose cap of mycobacterial lipoarabinomannan does not dominate the Mycobacterium-host interaction. Cell Microbiol (2007) 1.29
Identification of residues essential for catalysis and binding of calmodulin in Bordetella pertussis adenylate cyclase by site-directed mutagenesis. EMBO J (1989) 1.27
Cost of chickenpox in Canada: part II. Cost of complicated cases and total economic impact. The Immunization Monitoring Program-Active (IMPACT). Pediatrics (1999) 1.27
Properties of a human cytomegalovirus-induced protein kinase. Virology (1984) 1.27
Increased infiltration by monocytes in delayed type hypersensitivity site following cyclophosphamide treatment. Immunology (1978) 1.26
Local adoptive transfer of skin delayed-type hypersensitivity initiated by a single T lymphocyte. J Immunol (1982) 1.25
Identification of 12 new yeast mitochondrial ribosomal proteins including 6 that have no prokaryotic homologues. J Biol Chem (2001) 1.24
Relationship between fluorodeoxyglucose uptake in the large vessels and late aortic diameter in giant cell arteritis. Rheumatology (Oxford) (2008) 1.23
The kinetic occipital region in human visual cortex. Cereb Cortex (1997) 1.22
[Transfer of adenine-nucleotides through mitochondrial membranes during oxidative phosphorylation]. Bull Soc Chim Biol (Paris) (1970) 1.21
Focal liver lesions: evaluation of the efficacy of gadobenate dimeglumine in MR imaging--a multicenter phase III clinical study. Radiology (2000) 1.21
The kinetic occipital (KO) region in man: an fMRI study. Cereb Cortex (1997) 1.21
The phosphatidyl-myo-inositol anchor of the lipoarabinomannans from Mycobacterium bovis bacillus Calmette Guérin. Heterogeneity, structure, and role in the regulation of cytokine secretion. J Biol Chem (1997) 1.21
Human cortical regions involved in extracting depth from motion. Neuron (1999) 1.20
Mycobacterium tuberculosis H37Rv parietal and cellular lipoarabinomannans. Characterization of the acyl- and glyco-forms. J Biol Chem (2000) 1.20
BCG-induced protection in guinea pigs vaccinated and challenged via the respiratory route. Tuber Lung Dis (1993) 1.20
L3T4+ T cells able to mediate parasite-specific delayed-type hypersensitivity play a role in the pathology of experimental Chagas' disease. Eur J Immunol (1987) 1.20
Strength training: importance of genetic factors. Med Sci Sports Exerc (1998) 1.20
Isolation of a proline-rich mycobacterial protein eliciting delayed-type hypersensitivity reactions only in guinea pigs immunized with living mycobacteria. Proc Natl Acad Sci U S A (1993) 1.19
Idiopathic infantile arterial calcification with cardiac, renal and central nervous system involvement. Eur J Pediatr (1989) 1.19
Antigenic and structural similarities between Mycobacterium tuberculosis 50- to 55-kilodalton and Mycobacterium bovis BCG 45- to 47-kilodalton antigens. Infect Immun (1995) 1.18
Escherichia coli UMP-kinase, a member of the aspartokinase family, is a hexamer regulated by guanine nucleotides and UTP. Biochemistry (1995) 1.17
Relationships between the structure and the roles of lipoarabinomannans and related glycoconjugates in tuberculosis pathogenesis. Front Biosci (1998) 1.16
Isodense subdural haematomas on CT:MRI findings. Neuroradiology (1992) 1.16
Extraorbital inflammatory pseudotumor of the head and neck: CT and MR findings in three patients. AJNR Am J Neuroradiol (1999) 1.16
Patient acceptance for CT colonography: what is the real issue? Eur Radiol (2002) 1.15
Design for user efficiency in a dedicated ICU viewing station. Med Inform (Lond) (1995) 1.13
Novel mutation in 16S rRNA associated with streptomycin dependence in Mycobacterium tuberculosis. Antimicrob Agents Chemother (1995) 1.13
Staging and follow-up of rheumatoid arthritis of the knee. Comparison of sonography, thermography, and clinical assessment. J Ultrasound Med (1988) 1.12
High sensitivity of transgenic mice expressing soluble TNFR1 fusion protein to mycobacterial infections: synergistic action of TNF and IFN-gamma in the differentiation of protective granulomas. Eur J Immunol (1997) 1.12
Mannosylated lipoarabinomannan antagonizes Mycobacterium tuberculosis-induced macrophage apoptosis by altering Ca+2-dependent cell signaling. J Infect Dis (2000) 1.12
Structural elucidation by field desorption and electron-impact mass spectrometry of the C-mycosides isolated from Mycobacterium smegmatis. Biochim Biophys Acta (1983) 1.11
Mycobacterium smegmatis phosphoinositols-glyceroarabinomannans. Structure and localization of alkali-labile and alkali-stable phosphoinositides. J Biol Chem (1997) 1.11
Identification of KLF13 and KLF14 (SP6), novel members of the SP/XKLF transcription factor family. Genomics (2000) 1.10
Sinochoanal polyp and its variant, the angiomatous polyp: MRI findings. Eur Radiol (2001) 1.09
Ovarian vein embolization for the treatment of pelvic congestion syndrome: long-term technical and clinical results. J Vasc Interv Radiol (2000) 1.09
Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. Eur J Surg Oncol (1995) 1.09
Immunogenicity and protective capacity of Mycobacterium bovis BCG after oral or intragastric administration in mice. Vaccine (2000) 1.09
Cyclosporin A inhibits the delayed-type hypersensitivity reaction: impaired production of early pro-inflammatory mediator(s). Eur J Immunol (1984) 1.09
A nondegradative route for the removal of endotoxin from exopolysaccharides. Anal Biochem (1995) 1.09
Effective combination therapy for invasive pneumococcal pneumonia with ampicillin and intravenous immunoglobulins in a mouse model. Antimicrob Agents Chemother (2001) 1.09
Remote myocardial dysfunction after acute anterior myocardial infarction: impact of left ventricular shape on regional function: a magnetic resonance myocardial tagging study. J Am Coll Cardiol (2000) 1.08
[Calcium phosphate as adjuvant in vaccinations in man]. Ann Inst Pasteur (Paris) (1969) 1.08
Structural and catalytic characteristics of Escherichia coli adenylate kinase. J Biol Chem (1987) 1.08
Radiofrequency ablation for eradication of pulmonary tumor in rabbits. J Surg Res (2001) 1.07
Lipoarabinomannans: characterization of the multiacylated forms of the phosphatidyl-myo-inositol anchor by NMR spectroscopy. Biochem J (1999) 1.07
Additional value of PET-CT in the staging of lung cancer: comparison with CT alone, PET alone and visual correlation of PET and CT. Eur Radiol (2006) 1.06
Ex vivo experiment on radiofrequency liver ablation with saline infusion through a screw-tip cannulated electrode. J Surg Res (1997) 1.06
Autosomal dominant polycystic kidney disease in the neonatal period: association with a cerebral arteriovenous malformation. Pediatrics (1982) 1.06
A yeast homolog of chromatin assembly factor 1 is involved in early ribosome assembly. Curr Biol (2001) 1.05
Experimental liver cancers: Mn-DPDP-enhanced rims in MR-microangiographic-histologic correlation study. Radiology (1993) 1.05
Healthy aging, memory subsystems and regional cerebral oxygen consumption. Neuropsychologia (1995) 1.05
Repositioning and leaving in situ the central venous catheter during percutaneous treatment of associated superior vena cava syndrome: a report of eight cases. Cardiovasc Intervent Radiol (1999) 1.05
An ex vivo study on radiofrequency tissue ablation: increased lesion size by using an "expandable-wet" electrode. Eur Radiol (2001) 1.04
Newly found 2-N-acetyl-2,6-dideoxy-beta-glucopyranose containing methyl glucose polysaccharides in M.bovis BCG: revised structure of the mycobacterial methyl glucose lipopolysaccharides. Glycobiology (1998) 1.04